The clinical efficacy of -DOPA and STN-DBS share a common marker: reduced GABA content in the motor thalamus

por Stefani, A, Fedele, E, Vitek, J, Pierantozzi, M, Galati, S, Marzetti, F, Peppe, A, Bassi, M S, Bernardi, G, Stanzione, P
Publicado 2011

Randomized trial of safinamide add-on to levodopa in Parkinson's disease with motor fluctuations

por Borgohain, Rupam, Szasz, J, Stanzione, P, Meshram, C, Bhatt, M, Chirilineau, D, Stocchi, F, Lucini, V, Giuliani, R, Forrest, E, Rice, P, Anand, R
Publicado 2014

A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson’s disease patients

por Barone, P, Santangelo, G, Morgante, L, Onofrj, M, Meco, G, Abbruzzese, G, Bonuccelli, U, Cossu, G, Pezzoli, G, Stanzione, P, Lopiano, L, Antonini, A, Tinazzi, M
Publicado 2015